Kurve Technolog has aannounced a development and collaboration agreement with Seurat Therapeutics, Inc. of Chicago, IL. The license includes fields of use for their proprietary technology to be used for migraine prevention in adults.
“Both Seurat and Kurve are proud to be a part of making an effort to address the efficacy of migraine management,” said Marc Giroux, CEO of Kurve Technology.
“When Seurat co-founders, Dr. Richard Kraig, Dr. Martin Sanders and Yuan Zhang contacted me regarding this therapy, it was a natural fit. As a company, Kurve has been interested in this area for some time and Seurat’s approach offers a real opportunity. It’s an exciting time with this agreement to be moving forward with our proprietary technology platform.”
“We are pleased to see our business model of superior technology in a device that offers brand loyalty and market strength through the base unit and replaceable cartridges be accepted by Seurat and we foresee a bright future,” said Giroux.